![Thomas Folinsbee](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: - $ in data 31/03/2026
Thomas Folinsbee currently works at Shanghai Alebund Pharmaceuticals Ltd., as Director-Business Development from 2019 and CASI Pharmaceuticals, Inc., as Independent Director from 2023.
Mr. Folinsbee also formerly worked at 3SBio, Inc., as Director-Corporate Development from 2009 to 2019, Hisanaga Seisakusho Co. Ltd., as Director from 2011 to 2016, Bison Capital Acquisition Corp., as Independent Director from 2017 to 2019, Xynomic Pharmaceuticals Holdings, Inc., as Independent Director, and Summit Healthcare Acquisition Corp., as Independent Director.
Mr. Folinsbee received his undergraduate degree in 1990 from McGill University.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 30/04/2026 | 0 ( -.--% ) | - $ | 31/03/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| CASI PHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | 21/03/2023 |
Shanghai Alebund Pharmaceuticals Ltd. | Corporate Officer/Principal | 01/01/2019 |
| Società | Posizione | Fine |
|---|---|---|
Bison Capital Acquisition Corp.
 Bison Capital Acquisition Corp. Financial ConglomeratesFinance Operates as blank check company | Direttore/Membro del Consiglio | 01/01/2019 |
| 3SBIO INC. | Corporate Officer/Principal | 01/01/2019 |
Hisanaga Seisakusho Co. Ltd. | Direttore/Membro del Consiglio | 01/01/2016 |
| SUMT HEAL | Direttore/Membro del Consiglio | - |
| XYNOMIC PHARMACEUTICALS HOLDINGS, INC. | Direttore/Membro del Consiglio | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 8 |
|---|---|
3SBio, Inc.
 3SBio, Inc. BiotechnologyHealth Technology Engages in research, development, manufacturing and marketing of biopharmaceutical products | Health Technology |
McGill University
 McGill University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hisanaga Seisakusho Co. Ltd. | |
Bison Capital Acquisition Corp.
Bison Capital Acquisition Corp. Financial ConglomeratesFinance Operates as blank check company | Finance |
Xynomic Pharmaceuticals Holdings, Inc.
 Xynomic Pharmaceuticals Holdings, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and supplies oncology drugs | Health Technology |
Summit Healthcare Acquisition Corp.
 Summit Healthcare Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Shanghai Alebund Pharmaceuticals Ltd. | |
CASI Pharmaceuticals, Inc.
 CASI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics and pharmaceutical products | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
